Пегаспаргаза для инъекций 3750 МЕ/5 мл - Производитель и поставщик онкологических препаратов

Pegaspargase (3750IU) injection is used to treat Hodgkin’s disease in blood cancer patients. It is given by a medical professional only in his or her supervision. Side effects: This medicine may cause fever, nausea, fatigue, shortness of breath, abdominal pain, diarrhoea, , liver damage, changes in blood glucose level. Manufacturing info: Presentation: 3750IU Production capacity: 10 lakh Injection/month Our manufacturing facility is WHO-GMP and ISO 9001: 2001 certified. We follow the highest quality standards and our facility follows standard operating procedures recommended by FDA. We are exporting Pegaspargase (3750IU) injection more than 40 countries in Latin America, Africa, CIS, Asia, Middle East. We provide the below regulatory documents to our clients. 1. Certificate of Analysis (COA) 2. Method of Analysis (MOA) 3. Stability Data 4. Dossiers 5. Certificate of Pharmaceuticals Product (COPP) / (CPP) 6. Free Sale Certificate (FSC) We provide the products on customized manufacturing and third-party manufacturing to our international clients. We have earned our clients' confidence by providing faster delivery with the highest quality standards at affordable rates.